EML4 (2p21)
ALK (2p23.2)
constitutively activivation of ALK kinase domain
Crizotinib
Alectinib
Ceritinib
Brigatinib
Lorlatinib
Follicular lymphoma
Diffuse large B-cell lymphoma
Lung adenocarcinoma
Non-small cell lung adenocarcinoma
Thyroid carcinoma